Trump lines up MFN deals with nine mid-size pharmas on drug pricing push - Pharmaceutical Technology

These White House deals will require the nine midsize pharma companies to provide MFN prices to state Medicaid programmes nationally. These deals will require the companies to provide MFN prices to state Medicaid programmes nationally. The Trump administration has now secured an MFN deal with 26 global drugmakers. Image credit: noamgalai / Shutterstock.com. Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends. With a free Pharmaceutical Technology profile, you can: The leading site for news and procurement in the pharmaceutical industry

Source: Pharmaceutical Technology